Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function

Oral Diseases

Volumn 19, Issue 3, 2013, Pages 303-312

  Catalfamo, D L ^a   Britten, T M ^a   Storch, D I ^a   Calderon, N L ^a   Sorenson, H L ^a   Wallet, S M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

Bone resorption; Inflammatory mediators; Lipopolysaccharide; Osteoclasts; Type 2 diabetes

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ALVEOLAR BONE LOSS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL CULTURE; CELLS; CONTROLLED STUDY; HARVEST; HYPERGLYCEMIA; META ANALYSIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; ANIMAL; CELL DIFFERENTIATION; COMPLICATION; CYTOLOGY; HUMAN; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; MICE; OSTEOCLASTS;

EID: 84884314777     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12002     Document Type: Article

References (68)

1. Aguilar RB (2011). Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment success. Clin Ther 33: 408-424.
2. Ayilavarapu S, Kantarci A, Fredman G et al (2010). Diabetesinduced oxidative stress is mediated by Ca2 + -independent phospholipase A2 in neutrophils. J Immunol 184: 1507-1515.
3. Bar-Shavit Z (2007). The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem 102: 1130-1139.
4. Bascones-Martinez A, Matesanz-Perez P, Escribano-Bermejo M, Gonzalez-Moles MA, Bascones-Ilundain J, Meurman JH (2011). Periodontal disease and diabetes-Review of the Literature. Med Oral Patol Oral Cir Bucal. 16: e722-729.
5. Baumhauer JF, O'Keefe RJ, Schon LC, Pinzur MS (2006). Cytokine-induced osteoclastic bone resorption in charcot arthropathy: an immunohistochemical study. Foot Ankle Int 27: 797-800.
6. Blakytny R, Spraul M, Jude EB (2011). Review: The diabetic bone: a cellular and molecular perspective. Int J Low Extrem Wounds 10: 16-32.
7. Botolin S, McCabe LR (2007). Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 148: 198-205.
8. Braun T, Schett G (2012). Pathways for bone loss in inflammatory disease. Current osteoporosis reports 10: 101-108. Coleman DL (1982). Diabetes-obesity syndromes in mice. Diabetes 31: 1-6.
9. Coleman DL (1982). Diabetes-obesity syndromes in mice. Diabetes 31: 1-6.
10. O'Gradaigh D, Ireland D, Bord S, Compston JE (2004). Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis 63: 354-359.
11. Defronzo RA (2009). Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795.
12. Del Fattore A, Teti A, Rucci N (2008). Osteoclast receptors and signaling. Arch Biochem Biophys 473: 147-160.
13. Dumitrescu AL, Abd-El-Aleem S, Morales-Aza B, Donaldson LF (2004). A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation. J Clin Periodontol 31: 596-603.
14. Engebretson SP, Hey-Hadavi J, Ehrhardt FJ et al (2004). Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and type 2 diabetes. J Periodontol 75: 1203-1208.
15. Fernandez-Real JM, Pickup JC (2008). Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 19: 10-16.
16. Gillespie MT (2007). Impact of cytokines and T lymphocytes upon osteoclast differentiation and function. Arthritis Res Ther 9: 103.
17. Gough A, Abraha H, Li F et al (1997). Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med 14: 527-531.
18. Graves D (2008). Cytokines that promote periodontal tissue destruction. J Periodontol 79: 1585-1591.
19. Grey A, Mitnick MA, Masiukiewicz U et al (1999). A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 140: 4683-4690.
20. Hallmon WW, Mealey BL (1992). Implications of diabetes mellitus and periodontal disease. Diabetes Educ 18: 310-315.
21. Hayman AR (2008). Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity 41: 218-223.
22. Hotamisligil GS, Shargill NS, Spiegelman BM (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesitylinked insulin resistance. Science (New York, NY) 259: 87-91.
23. Jiang J, Zuo J, Hurst IR, Holliday LS (2003). The synergistic effect of peptidoglycan and lipopolysaccaride on osteoclast formation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 738-743.
24. Karima M, Kantarci A, Ohira T et al (2005). Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol 78: 862-870.
25. Kinane DF (2001). Causation and pathogenesis of periodontal disease. Periodontology 2000 25: 8-20.
26. Knowles HJ, Athanasou NA (2009). Canonical and non-canonical pathways of osteoclast formation. Histol Histopathol 24: 337-346.
27. Lalla E, Cheng B, Lal S et al (2006). Periodontal changes in children and adolescents with diabetes: a case-control study. Diabetes Care 29: 295-299.
28. Larsen KI, Falany ML, Ponomareva LV, Wang W, Williams JP (2002). Glucose-dependent regulation of osteoclast H(+)-ATPase expression: potential role of p38 MAP-kinase. J Cell Biochem 87: 75-84.
29. Larsen KI, Falany M, Wang W, Williams JP (2005). Glucose is a key metabolic regulator of osteoclasts; glucose stimulated increases in ATP/ADP ratio and calmodulin kinase II activity. Biochem Cell Biol 83: 667-673.
30. Leibel RL, Chung WK, Chua SC, Jr (1997). The molecular genetics of rodent single gene obesities. J Biol Chem 272: 31937-31940.
31. Liu R, Bal HS, Desta T et al (2006). Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 85: 510-514.
32. Liu J, Wang S, Zhang P, Said-Al-Naief N, Michalek SM, Feng X (2009). Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis. J Biol Chem 284: 12512-12523.
33. Loe H (1993). Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 16: 329-334.
34. Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A (2008). Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia 51: 1035-1040.
35. Matsuo K, Irie N (2008). Osteoclast-osteoblast communication. Arch Biochem Biophys 473: 201-209.
36. McMullen JA, Van Dyke TE, Horoszewicz HU, Genco RJ (1981). Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol 52: 167-173.
37. Mealey B (1999a). Diabetes and periodontal diseases. J Periodontol 70: 935-949.
38. Mealey BL (1999b). Influence of periodontal infections on systemic health. Periodontology 2000 21: 197-209.
39. Mealey BL, Oates TW (2006). Diabetes mellitus and periodontal diseases. J Periodontol 77: 1289-1303.
40. Mealey BL, Rose LF (2008). Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes 15: 135-141.
41. Motyl K, McCabe LR (2009). Streptozotocin, type I diabetes severity and bone. Biol Proced Online 11: 296-315.
42. Naguib G, Al-Mashat H, Desta T, Graves DT (2004). Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 123: 87-92.
43. Nanci A, Bosshardt DD (2006). Structure of periodontal tissues in health and disease. Periodontology 2000 40: 11-28.
44. Nelson RG, Shlossman M, Budding LM et al (1990). Periodontal disease and NIDDM in Pima Indians. Diabetes Care 8: 836-840.
45. Ng KW (2011). Regulation of glucose metabolism and the skeleton. Clin Endocrinol 75: 147-155.
46. Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, Gyurko R (2011). State of the union between metabolism and the immune system in type 2 diabetes. Genes Immun 12: 239-250.
47. Oursler MJ (2010). Recent advances in understanding the mechanisms of osteoclast precursor fusion. J Cell Biochem 110: 1058-1062.
48. Pacios S, Kang J, Galicia J et al (2012). Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. Faseb J 4: 1423-1430.
49. Page RC, Kornman KS (1997). The pathogenesis of human periodontitis: an introduction. Periodontology 2000 14: 9-11.
50. Papapanou PN (1996). Periodontal diseases: epidemiology. Ann Periodontol 1: 1-36.
51. Poubelle PE, Chakravarti A, Fernandes MJ, Doiron K, Marceau AA (2007). Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils. Arthritis Res Ther 9: R25.
52. Raggatt LJ, Partridge NC (2010). Cellular and molecular mechanisms of bone remodeling. J Biol Chem 285: 25103-25108.
53. Roszer T (2011). Inflammation as death or life signal in diabetic fracture healing. Inflamm Res 60: 3-10.
54. Ryan ME, Carnu O, Kamer A (2003). The influence of diabetes on the periodontal tissues. J Am Dent Assoc 134 Spec No: 34S-40S.
55. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S (1997a). Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 24: 8-16.
56. Salvi GE, Yalda B, Collins JG et al (1997b). Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 68: 127-135.
57. Sandberg GE, Sundberg HE, Fjellstrom CA, Wikblad KF (2000). Type 2 diabetes and oral health: a comparison between diabetic and non-diabetic subjects. Diabetes Res Clin Pract 50: 27-34.
58. Suzuki K, Kurose T, Takizawa M et al (2005). Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. Diabetes Res Clin Pract 68: 117-125.
59. Takahashi N, Udagawa N, Tanaka S et al (1994). Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Dev Biol 163: 212-221.
60. Takami M, Kim N, Rho J, Choi Y (2002). Stimulation by tolllike receptors inhibits osteoclast differentiation. J Immunol 169: 1516-1523.
61. Takayanagi H (2007). Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7: 292-304.
62. Takayanagi H (2009). Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol 5: 667-676.
63. Tamasi JA, Arey BJ, Bertolini DR, Feyen JH (2003). Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats. J Bone Miner Res 18: 1605-1611.
64. Taubman MA, Valverde P, Han X, Kawai T (2005). Immune response: the key to bone resorption in periodontal disease. J Periodontol 76: 2033-2041.
65. Teng YT (2006). Protective and destructive immunity in the periodontium: part 1-innate and humoral immunity and the periodontium. J Dent Res 85: 198-208.
66. Tsai C, Hayes C, Taylor GW (2002). Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 30: 182-192.
67. Williams JP, Blair HC, McDonald JM et al (1997). Regulation of osteoclastic bone resorption by glucose. Biochem Biophys Res Commun 235: 646-651.
68. Wittrant Y, Gorin Y, Woodruff K et al (2008). High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone 42: 1122-1130.